Fumoleau, P <br/><br/>
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Mar 2004 
 - 536-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2003.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anthracyclines--therapeutic use<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Bridged-Ring Compounds--therapeutic use<br/>Capecitabine<br/>Deoxycytidine--analogs & derivatives<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Quality of Life<br/>Taxoids--therapeutic use<br/>Treatment Outcome